GB9320943D0 - Peptide-protein conjugate vaccines having anionic spacers - Google Patents

Peptide-protein conjugate vaccines having anionic spacers

Info

Publication number
GB9320943D0
GB9320943D0 GB939320943A GB9320943A GB9320943D0 GB 9320943 D0 GB9320943 D0 GB 9320943D0 GB 939320943 A GB939320943 A GB 939320943A GB 9320943 A GB9320943 A GB 9320943A GB 9320943 D0 GB9320943 D0 GB 9320943D0
Authority
GB
United Kingdom
Prior art keywords
peptide
protein conjugate
conjugate vaccines
spacers
anionic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB939320943A
Other versions
GB2271995A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9320943D0 publication Critical patent/GB9320943D0/en
Publication of GB2271995A publication Critical patent/GB2271995A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB9320943A 1992-10-15 1993-10-12 HIV peptide conjugated via anionic spacer to protein Withdrawn GB2271995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96332792A 1992-10-15 1992-10-15

Publications (2)

Publication Number Publication Date
GB9320943D0 true GB9320943D0 (en) 1993-12-01
GB2271995A GB2271995A (en) 1994-05-04

Family

ID=25507081

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9320943A Withdrawn GB2271995A (en) 1992-10-15 1993-10-12 HIV peptide conjugated via anionic spacer to protein

Country Status (1)

Country Link
GB (1) GB2271995A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2282379A (en) * 1993-09-30 1995-04-05 Merck & Co Inc Conjugates of epitopes of HIV with a protein complex from Neisseria
GB2282378A (en) * 1993-09-30 1995-04-05 Merck & Co Inc Conjugates of epitopes of HIV with a protein complex from Neisseria
FR2776926B1 (en) * 1998-04-07 2003-10-24 Inst Nat Sante Rech Med LYMPHOCYTARY T CYTOTOXICITY T INDUCING LIPOPEPTIDES CARRYING AT LEAST ONE AUXILIARY T EPITOPE, AND THEIR USES FOR VACCINATION
EP1704167B1 (en) * 2003-12-18 2011-01-12 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. A method to make a peptide-carrier conjugate with a high immunogenicity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE912559A1 (en) * 1990-07-19 1992-01-29 Merck & Co Inc The class ii protein of the outer membrane of neisseria¹meningitidis, and vaccines containing same
CA2047031A1 (en) * 1990-07-19 1992-01-20 Stephen Marburg Peptide-polysaccharide-protein conjugate vaccines
IL98845A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
EP0519554A1 (en) * 1991-06-19 1992-12-23 Merck & Co. Inc. Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides

Also Published As

Publication number Publication date
GB2271995A (en) 1994-05-04

Similar Documents

Publication Publication Date Title
AP9300530A0 (en) Vaccines
CZ197595A3 (en) Vaccine preparations
ZA947828B (en) Vaccines
EP0640096A4 (en) Universal coronavirus vaccine.
HUT70981A (en) Conjugate vaccine against group b streptococcus
GB9325496D0 (en) Vaccines
GB9320943D0 (en) Peptide-protein conjugate vaccines having anionic spacers
GB9215233D0 (en) Vaccines
GB9201023D0 (en) Vaccines
GB9213559D0 (en) Vaccines
GB9214871D0 (en) Vaccines
GB9322702D0 (en) Vaccines
ZA93919B (en) Vaccines
GR3032256T3 (en) Babesia vaccine
GB9322808D0 (en) Vaccines
ZA939564B (en) Vaccines.
GB9211081D0 (en) Vaccines
GB9305710D0 (en) Viral vaccines
GB9324964D0 (en) Viral vaccines
GB9307028D0 (en) Vaccine
GB9213308D0 (en) Vaccine
GB9206797D0 (en) Vaccine
GB9206789D0 (en) Vaccine
GB9206788D0 (en) Vaccine
GB9206786D0 (en) Vaccine

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)